In CKD, particularly in advanced stages or in patients undergoing dialysis, circulating renalase levels are often significantly elevated and correlate with disease severity, inflammation, and adverse outcomes, including all-cause mortality and MACE (in some studies). This evidence concerns the gene RNLS and chronic kidney disease.